de With K, Steib-Bauert M, Straach P, Kern W V
Center for Infectious Diseases and Travel Medicine, University Hospital, Hugstetter Str. 55, 79106, Freiburg, Germany.
Infection. 2006 Oct;34(5):274-7. doi: 10.1007/s15010-006-6617-z.
Outpatient antibiotic use in Germany differs substantially between eastern and southern parts of the country (low use) and the western part (high use). Whether similar regional variation exists in hospital antibiotic consumption is not known. We investigated this issue using a convenience sample of 145 hospitals providing data for the year 2003.
Data on hospital consumption of systemic antibiotics in Anatomical Therapeutic Chemical (ATC) class J01 were obtained from acute care hospitals that participated in an IMS survey and had complete data (dispensed drugs and patient-days per year) for at least one non-pediatric, non-psychiatric department or ward. A total of 275 non-ICU surgical departments/wards, 229 non-ICU non-surgical (general medicine, haematology-oncology, neurology/stroke) departments/wards, and 184 ICUs were analysed. Data were expressed in DDD (WHO/ATC definition version 2003) or daily doses adapted for recommendations in hospitalized patients (RDD) per 100 patient days (DDD/100 and RDD/100).
The weighted mean over all departments/wards was 49.6 DDD/100 or 31.3 RDD/100, respectively. As expected, ICU antibiotic use density was much higher than use in non-ICU areas, and use in haematology-oncology was higher than in other non-surgical departments/wards. In univariate analyses, region, hospital bed-size category, university affiliation and haematology-oncology as specialty were associated with use density, but these associations were only partly confirmed in multivariate logistic regression analyses of factors associated with excess (> or = 75%) use density which showed university affiliation and haematology-oncology but not hospital location to be independently associated with comparatively high use.
Antibiotic use density in German acute care hospitals does not appear to differ significantly between regions. Overall hospital consumption of antibiotics in this country appears to be similar to what has been described from other parts of Europe. In comparative analyses of hospital antibiotic consumption, data need to be adjusted at least for university affiliation and haematology-oncology.
德国门诊抗生素使用情况在该国东部和南部地区(使用量低)与西部地区(使用量高)之间存在显著差异。尚不清楚医院抗生素消费是否存在类似的地区差异。我们使用了145家医院的便利样本进行调查,这些医院提供了2003年的数据。
从参与IMS调查且至少有一个非儿科、非精神科科室或病房具备完整数据(每年发放的药品和患者住院天数)的急性护理医院获取解剖治疗化学(ATC)分类J01中全身用抗生素的医院消费数据。共分析了275个非重症监护病房外科科室/病房、229个非重症监护病房非外科(普通内科、血液肿瘤学、神经科/中风)科室/病房以及184个重症监护病房。数据以每100患者住院天数的限定日剂量(DDD,世界卫生组织/ATC定义版本2003)或根据住院患者推荐剂量调整后的每日剂量(RDD)表示(DDD/100和RDD/100)。
所有科室/病房的加权平均值分别为49.6 DDD/100或31.3 RDD/100。正如预期的那样,重症监护病房的抗生素使用密度远高于非重症监护病房区域,血液肿瘤学科室的使用量高于其他非外科科室/病房。在单因素分析中,地区、医院床位规模类别、大学附属关系以及血液肿瘤学专业与使用密度相关,但在对与过量(≥75%)使用密度相关因素的多因素逻辑回归分析中,这些关联仅部分得到证实,该分析显示大学附属关系和血液肿瘤学专业与较高使用量独立相关,而医院位置并非如此。
德国急性护理医院的抗生素使用密度在各地区之间似乎没有显著差异。该国医院抗生素的总体消费量似乎与欧洲其他地区所描述的情况相似。在医院抗生素消费的比较分析中,数据至少需要根据大学附属关系和血液肿瘤学专业进行调整。